RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.

Beginning on 1/1/2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions. Effective 7/1/3000. (HD1)

Voted 2/8/2024

Roll-call record

How representatives voted

8 yea·0 nay

Lisa Marten
State Representative · Democratic · HI
Yea
Della Belatti
State Representative · Democratic · HI
Yea
Diamond Garcia
State Representative · Republican · HI
Yea
Terez Amato
State Representative · Democratic · HI
Yea
Jenna Takenouchi
State Representative · Democratic · HI
Yea
Greggor Ilagan
State Representative · Democratic · HI
Yea
Bert Kobayashi
State Representative · HI
Yea
Scott Nishimoto
State Representative · HI
Yea

Docket history

Action history

2/8/2024Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC with none voting aye with reservations; none voting no (0) and Representative(s) Nakashima, Nishimoto, Sayama, Ward excused (4).
2/8/2024Reported from HLT (Stand. Com. Rep. No. 199-24) as amended in HD 1, recommending passage on Second Reading and referral to CPC.
2/7/2024The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Belatti, Takenouchi, Amato, Ilagan, Kobayashi, Marten, Nishimoto, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.
2/2/2024Bill scheduled to be heard by HLT on Wednesday, 02-07-24 9:45AM in House conference room 329 VIA VIDEOCONFERENCE.
12/11/2023Carried over to 2024 Regular Session.
1/30/2023Referred to HLT, CPC, FIN, referral sheet 3
1/25/2023Introduced and Pass First Reading.
1/23/2023Pending introduction.